Ucb SA 2014 AR2
The report highlights UCB's performance in 2014, focusing on its patient-centric strategy in neurology and immunology. UCB reached 710,000 patients with its core medicines Cimzia, Vimpat, and Neupro, which generated combined net sales of ’1.47 billion, representing 50% of total net sales. Financially, the company achieved revenue of ’3.34 billion and a recurring EBITDA of ’609 million. On the environmental front, UCB reduced its overall energy consumption by 12% and CO2 emissions by 17%, while successfully recovering 94% of its waste. Additionally, UCB launched several access-to-healthcare initiatives, such as Project Dandelion in China and the Mozambique Epilepsy Initiative.
Company: Ucb SA
Sector: Manufacturing
Country: Belgium
Year: 2014
Type: AR2
Pages: 178
Back to company
Ucb SA
Annual Report
The report highlights UCB's performance in 2014, focusing on its patient-centric strategy in neurology and immunology. UCB reached 710,000 patients with its core medicines Cimzia, Vimpat, and Neupro, which generated combined net sales of ’1.47 billion, representing 50% of total net sales. Financially, the company achieved revenue of ’3.34 billion and a recurring EBITDA of ’609 million. On the environmental front, UCB reduced its overall energy consumption by 12% and CO2 emissions by 17%, while successfully recovering 94% of its waste. Additionally, UCB launched several access-to-healthcare initiatives, such as Project Dandelion in China and the Mozambique Epilepsy Initiative.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Employees